Hyperglycaemia and reduced glucokinase expression in weanling offspring from dams maintained on a high-fat diet.
High-fat feeding reduces the expression of GLUT-2 and the glycolytic enzyme glucokinase (GK). The transcription factor, pancreatic duodenal homeobox-1 (Pdx-1), is important for beta-cell maintenance. The aim of the present study was to determine, in weanling Wistar rats, the effect of a maternal high-fat diet (HFD) during defined periods of gestation and lactation, on body weight, circulating glucose and insulin concentrations, and the expression of GLUT-2, GK and Pdx-1. At postnatal day 21, weights were recorded and glucose and insulin concentrations were measured. The expression levels for mRNA were quantified by LightCycler PCR. Pancreatic sections, immunostained for GLUT-2, GK or Pdx-1, were assessed by image analysis. Weanlings from dams fed an HFD throughout gestation were lighter, with heavier weanlings produced from dams fed an HFD throughout gestation and lactation. Both these groups of weanlings were normoglycaemic, all the others being hyperglycaemic. Hypoinsulinaemia was evident in weanlings from dams fed an HFD throughout gestation only and also for either the first week of lactation or throughout lactation. GLUT-2 mRNA expression was reduced and GLUT-2 immunoreactivity was increased in most of the weanlings. GK mRNA expression and immunoreactivity was reduced in most of the offspring. Pdx-1 mRNA expression was increased in weanlings from dams fed an HFD throughout both gestation and lactation and reduced in those from dams only fed a lactational HFD. Normal Pdx-1 immunoreactivity was found in all of the weanlings. A maternal HFD induces hyperglycaemia in weanlings concomitant with reduced GK expression which may compromise beta-cell function.
Cerf
Marlon E
ME
Diabetes Research Group, Medical Research Council, Tygerberg, South Africa. marlon.cerf@mrc.ac.za
Muller
Christo J
CJ
Du Toit
Don F
DF
Louw
Johan
J
Wolfe-Coote
Sonia A
SA
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001835:Body Weight / Q000502:physiology; D004041:Dietary Fats / Q000008:administration & dosage*; D005260:Female; D005786:Gene Expression Regulation; D005941:Glucokinase / Q000097:blood*; D051273:Glucose Transporter Type 2 / Q000097:blood; D018398:Homeodomain Proteins / Q000097:blood; D006943:Hyperglycemia / Q000097:blood / Q000209:etiology*; D007328:Insulin / Q000097:blood; D008431:Maternal-Fetal Exchange / Q000502:physiology*; D011247:Pregnancy; D012333:RNA, Messenger / Q000097:blood; D051381:Rats; D017208:Rats, Wistar; D015534:Trans-Activators / Q000097:blood; D014886:Weaning
D001786:Blood Glucose; D004041:Dietary Fats; D051273:Glucose Transporter Type 2; D018398:Homeodomain Proteins; D007328:Insulin; D012333:RNA, Messenger; C495683:Slc2a2 protein, rat; D015534:Trans-Activators; C084010:pancreatic and duodenal homeobox 1 protein; D005941:Glucokinase